MDA (Medical Devices Agency) on "persistent" false positive blood cultures:
This article was originally published in Clinica
A persistently high number of false positive blood culture results involving inappropriate phlebotomy techniques is resulting in delays in identifying the true cause of bacteraemias and in unnecessary treatment with antibiotics, says the Medical Devices Agency. Inadequate decontamination is at the centre of the problem, which the agency first reported in January 1998, highlighting the need to use new needles.
You may also be interested in...
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
US FDA Will Need About A Week To Complete COVID Vaccine Assessment Following Advisory Cmte., CBER’s Marks Says
Timeline is the most pessimistic public projection to date, but still incredibly fast. Clinical trial patients on placebo could be contacted and offered the vaccine after an EUA is granted.
Operation Warp Speed chief scientific advisor confirms doubts about the Phase III data from two UK and Brazil studies; says efficacy results in US trials of AstraZeneca and Janssen vaccines expected by mid-January.